WO2000042063A3 - Peptides for inhibiting hbv core proteins - Google Patents
Peptides for inhibiting hbv core proteins Download PDFInfo
- Publication number
- WO2000042063A3 WO2000042063A3 PCT/DE2000/000140 DE0000140W WO0042063A3 WO 2000042063 A3 WO2000042063 A3 WO 2000042063A3 DE 0000140 W DE0000140 W DE 0000140W WO 0042063 A3 WO0042063 A3 WO 0042063A3
- Authority
- WO
- WIPO (PCT)
- Prior art keywords
- peptides
- core proteins
- inhibiting hbv
- hbv core
- inhibiting
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/16—Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/20—Antivirals for DNA viruses
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2730/00—Reverse transcribing DNA viruses
- C12N2730/00011—Details
- C12N2730/10011—Hepadnaviridae
- C12N2730/10111—Orthohepadnavirus, e.g. hepatitis B virus
- C12N2730/10122—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Veterinary Medicine (AREA)
- Virology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Public Health (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Molecular Biology (AREA)
- Gastroenterology & Hepatology (AREA)
- Engineering & Computer Science (AREA)
- Oncology (AREA)
- Communicable Diseases (AREA)
- Biotechnology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Biochemistry (AREA)
- Biophysics (AREA)
- Genetics & Genomics (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Peptides Or Proteins (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
Abstract
Priority Applications (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
EP00908930A EP1140995A2 (en) | 1999-01-13 | 2000-01-12 | Peptides for inhibiting hbv core proteins |
JP2000593630A JP2002534111A (en) | 1999-01-13 | 2000-01-12 | HBV core protein inhibitory peptide |
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
DE19901009.9 | 1999-01-13 | ||
DE19901009A DE19901009A1 (en) | 1999-01-13 | 1999-01-13 | Peptides to inhibit HBV core proteins |
Publications (2)
Publication Number | Publication Date |
---|---|
WO2000042063A2 WO2000042063A2 (en) | 2000-07-20 |
WO2000042063A3 true WO2000042063A3 (en) | 2000-12-14 |
Family
ID=7894120
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PCT/DE2000/000140 WO2000042063A2 (en) | 1999-01-13 | 2000-01-12 | Peptides for inhibiting hbv core proteins |
Country Status (4)
Country | Link |
---|---|
EP (1) | EP1140995A2 (en) |
JP (1) | JP2002534111A (en) |
DE (1) | DE19901009A1 (en) |
WO (1) | WO2000042063A2 (en) |
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US8859518B2 (en) | 2004-04-22 | 2014-10-14 | Regado Biosciences, Inc. | Modulators of coagulation factors |
Families Citing this family (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP2325337A1 (en) | 2000-09-26 | 2011-05-25 | Duke University | RNA aptamers and methods for identifying the same |
IL159053A0 (en) | 2001-05-25 | 2004-05-12 | Univ Duke | Modulators of pharmacological agents |
CN102268066B (en) * | 2010-06-01 | 2014-01-22 | 雷海民 | Anti-HBV oligopeptides and derivatives thereof |
Family Cites Families (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
GB9016727D0 (en) * | 1990-07-31 | 1990-09-12 | Clonit Spa | Amino acid residue sequence of hepatitis b core antigen |
-
1999
- 1999-01-13 DE DE19901009A patent/DE19901009A1/en not_active Withdrawn
-
2000
- 2000-01-12 WO PCT/DE2000/000140 patent/WO2000042063A2/en not_active Application Discontinuation
- 2000-01-12 EP EP00908930A patent/EP1140995A2/en not_active Withdrawn
- 2000-01-12 JP JP2000593630A patent/JP2002534111A/en active Pending
Non-Patent Citations (1)
Title |
---|
MICHAEL R. DYSON ET AL.: "Selection of peptide inhibitors of interactions involved in complex protein assemblies: association of the core and surface antigens of hepatitis B virus", PROC.NATL.ACAD.SCI., vol. 92, 1995, pages 2194 - 8, XP002141206 * |
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US8859518B2 (en) | 2004-04-22 | 2014-10-14 | Regado Biosciences, Inc. | Modulators of coagulation factors |
Also Published As
Publication number | Publication date |
---|---|
JP2002534111A (en) | 2002-10-15 |
WO2000042063A2 (en) | 2000-07-20 |
EP1140995A2 (en) | 2001-10-10 |
DE19901009A1 (en) | 2000-07-20 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
AU2001292757A1 (en) | Modified selex processes without purified protein | |
ZA983496B (en) | Methods for processing activated protein C. | |
WO2001053312A8 (en) | Novel nucleic acids and polypeptides | |
WO2001053455A3 (en) | Novel nucleic acids and polypeptides | |
MXPA02010787A (en) | Modified peptides as therapeutic agents. | |
AU2002217010A1 (en) | Peptides, the production and use thereof for binding immunoglobulins | |
AU6114700A (en) | Novel system for the sequential, directional cloning of multiple dna sequences | |
WO1999020747A3 (en) | HUMAN CHECKPOINT KINASE, hCDS1, COMPOSITIONS AND METHODS | |
EP1129106A4 (en) | Cyclised conotoxin peptides | |
EP1273658A4 (en) | Novel protein, dna thereof and process for producing the same | |
ZA200205408B (en) | Process for the preparation of peptides. | |
AU2001282037A1 (en) | Proton-translocating retinal protein | |
AU2001279581A1 (en) | Medicament comprising a dna sequence, which codes for the rna-binding koc protein, and comprising a koc protein or dna sequence of the koc promoter | |
WO2000042063A3 (en) | Peptides for inhibiting hbv core proteins | |
MXPA04002103A (en) | A caspase- 8 binding protein, its preparation and use. | |
AU2002215386A1 (en) | Isolated human kinase proteins, nucleic acid molecules encoding human kinase proteins, and uses thereof | |
WO2001053453A3 (en) | Novel bone marrow nucleic acids and polypeptides | |
AU3556800A (en) | Expression of dna or proteins in (c. elegans) | |
AU2001286687A1 (en) | Isolated human kinase proteins, nucleic acid molecules encoding human kinase proteins, and uses thereof | |
AU2001295580A1 (en) | Nucleotide sequences which code for the dep67 protein | |
AU2001290872A1 (en) | Isolated human kinase proteins, nucleic acid molecules and uses thereof | |
AU2002213259A1 (en) | Egf motif protein, egfl6 materials and methods | |
AU2002232599A1 (en) | Isolated human kinase proteins, nucleic acid molecules encoding human kinase proteins, and uses thereof | |
WO1999053091A3 (en) | Dna coding for gdnf, parts of said dna and gdnf variants | |
ZA99445B (en) | Isolated, polypeptides which bind to HLA-A29 molecules nucleic acid, the molecules encoding these, and uses thereof. |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
AK | Designated states |
Kind code of ref document: A2 Designated state(s): JP US |
|
AL | Designated countries for regional patents |
Kind code of ref document: A2 Designated state(s): AT BE CH CY DE DK ES FI FR GB GR IE IT LU MC NL PT SE |
|
121 | Ep: the epo has been informed by wipo that ep was designated in this application | ||
DFPE | Request for preliminary examination filed prior to expiration of 19th month from priority date (pct application filed before 20040101) | ||
AK | Designated states |
Kind code of ref document: A3 Designated state(s): JP US |
|
AL | Designated countries for regional patents |
Kind code of ref document: A3 Designated state(s): AT BE CH CY DE DK ES FI FR GB GR IE IT LU MC NL PT SE |
|
ENP | Entry into the national phase |
Ref country code: JP Ref document number: 2000 593630 Kind code of ref document: A Format of ref document f/p: F |
|
WWE | Wipo information: entry into national phase |
Ref document number: 2000908930 Country of ref document: EP |
|
WWE | Wipo information: entry into national phase |
Ref document number: 09889135 Country of ref document: US |
|
WWP | Wipo information: published in national office |
Ref document number: 2000908930 Country of ref document: EP |
|
WWW | Wipo information: withdrawn in national office |
Ref document number: 2000908930 Country of ref document: EP |